SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Deals
What Happens When a Biotech Gets Bought Out
September 9, 2008
 · 
1 min read
Biotech Bay
Study Outcome Won’t Sway Genentech, Inc. On Eye Drug
August 28, 2008
 · 
1 min read
Job Trends
Recruiters Eye Genentech, Inc. Employees
August 18, 2008
 · 
1 min read
Drug Development
Genentech, Inc. and Biogen Idec, Inc. (Massachusetts) Rituxan May Heal Common Kidney Condition
August 7, 2008
 · 
1 min read
‘Total’ Sunblock Claims Excessive, Consumer Council Warns
July 15, 2008
 · 
1 min read
Biotech Bay
Genentech, Inc.'s (JOBS) Avastin Cost Debated Before Wider Use
July 7, 2008
 · 
1 min read
Biotech Bay
Small is Beautiful -- BioPharm Executive
June 25, 2008
 · 
2 min read
Policy
Genentech, Inc. Spent $591,000 Lobbying The Federal Government On Biotech Issues In First Quarter
June 2, 2008
 · 
1 min read
Drug Development
Skin Cancer Breakthrough? Genentech, Inc. and Curis, Inc. Experimental Drug GDC-0449 Shrinks Advanced Skin Cancer
April 15, 2008
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
December 22, 2025
 · 
16 min read
Press Releases
Genentech Announces Agreement With U.S. Government
December 22, 2025
 · 
2 min read
Press Releases
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
December 17, 2025
 · 
3 min read
Press Releases
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
December 17, 2025
 · 
6 min read
Press Releases
Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer
December 11, 2025
 · 
7 min read
Press Releases
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
December 10, 2025
 · 
13 min read
Press Releases
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
December 9, 2025
 · 
19 min read
Press Releases
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors
November 20, 2025
 · 
2 min read
Press Releases
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
November 19, 2025
 · 
8 min read
Press Releases
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
November 19, 2025
 · 
7 min read
Load More